CORC  > 兰州大学  > 兰州大学  > 第二临床医学院  > 期刊论文
Insulin resistance contributes to multidrug resistance in HepG2 cells via activation of the PERK signaling pathway and upregulation of Bcl-2 and P-gp
Liu, XY; Li, LJ; Li, J; Cheng, Y; Chen, J; Shen, MH; Zhang, SD; Wei, HL
刊名ONCOLOGY REPORTS
2016-05
卷号35期号:5页码:3018-3024
关键词insulin resistance multidrug resistance HepG2 PERK pathway upregulation
ISSN号1021-335X
通讯作者Wei, HL (reprint author), Lanzhou Univ, Sch Basic Med Sci, 199 Donggang West Rd, Lanzhou 730000, Gansu, Peoples R China.
学科主题Oncology
收录类别SCIE ; PUBMED ; MEDLINE ; BIOSIS
出版地ATHENS
语种英语
WOS记录号WOS:000374077700060
内容类型期刊论文
源URL[http://ir.lzu.edu.cn/handle/262010/179437]  
专题第二临床医学院_期刊论文
推荐引用方式
GB/T 7714
Liu, XY,Li, LJ,Li, J,et al. Insulin resistance contributes to multidrug resistance in HepG2 cells via activation of the PERK signaling pathway and upregulation of Bcl-2 and P-gp[J]. ONCOLOGY REPORTS,2016,35(5):3018-3024.
APA Liu, XY.,Li, LJ.,Li, J.,Cheng, Y.,Chen, J.,...&Wei, HL.(2016).Insulin resistance contributes to multidrug resistance in HepG2 cells via activation of the PERK signaling pathway and upregulation of Bcl-2 and P-gp.ONCOLOGY REPORTS,35(5),3018-3024.
MLA Liu, XY,et al."Insulin resistance contributes to multidrug resistance in HepG2 cells via activation of the PERK signaling pathway and upregulation of Bcl-2 and P-gp".ONCOLOGY REPORTS 35.5(2016):3018-3024.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace